Abstract
Recently, it was proposed that the thiophene ring is capable of promoting mitochondrial accumulation when linked to fluorescent markers. As a noncharged group, thiophene presents several advantages from a synthetic point of view, making it easier to incorporate such a side moiety into different molecules. Herein, we confirm the general applicability of the thiophene group as a mitochondrial carrier for drugs and fluorescent markers based on a new concept of nonprotonable, noncharged transporter. We implemented this concept in a medicinal chemistry application by developing an antitumor, metabolic chimeric drug based on the pyruvate dehydrogenase kinase (PDHK) inhibitor dichloroacetate (DCA). The promising features of the thiophene moiety as a noncharged carrier for targeting mitochondria may represent a starting point for the design of new metabolism-targeting drugs.
Highlights
We showed that simple acridone-based fluorescent probe 1, containing a thiophene side group (Chart 1), exhibited enhanced mitochondrial accumulation compared to its thiophene-lacking counterpart [40]
Apart from acridone 1, we synthesized a xanthene derivative with the thiophene group included on a flexible chain (2), a xanthene derivative with the thiophene incorporated in the central ring (3) and a BODIPY derivative (4)
In seeking new, noncharged organelle-targeting carriers, we found that neutral acridone dyes underwent mitochondrial accumulation when modified with a thiophene ring [40]
Summary
Mitochondria are essential organelles for cellular metabolism; understanding their function is critical for biologists and biochemists [1]. Cellular metabolism, through mitochondrial activity, plays a central role in many physiological alterations and diseases. Alterations in mitochondrial metabolism play a crucial role in cancer [2,3]. The anabolic pathways derived from the mitochondrial oxidative metabolism, such as tricarboxylic acid cycle (TCA)-derived biosynthetic reactions, are significantly essential to sustain high proliferative rates in many cancer types [4]. Other cancer cells display an apparent independence on mitochondrial oxidative metabolism, Pharmaceutics 2021, 13, 254.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have